-
1
-
-
41149142016
-
Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol
-
Apte, R. N. and Voronov, E. (2008). Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol. Rev. 222, 222-241.
-
(2008)
Rev
, vol.222
, pp. 222-241
-
-
Apte, R.N.1
Voronov, E.2
-
2
-
-
30944459963
-
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras- induced transformation
-
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. and Gudkov, A. V. (2006). A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras- induced transformation. Genes Dev. 20, 236-252.
-
(2006)
Genes Dev
, vol.20
, pp. 236-252
-
-
Boiko, A.D.1
Porteous, S.2
Razorenova, O.V.3
Krivokrysenko, V.I.4
Williams, B.R.5
Gudkov, A.V.6
-
3
-
-
0024376173
-
ras oncogenes in human cancer: a review
-
Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
-
(1989)
Cancer Res
, vol.49
, pp. 4682-4689
-
-
Bos, J.L.1
-
4
-
-
70349443284
-
When mutants gain new powers: news from the mutant p53 field
-
Brosh, R. and Rotter, V. (2009). When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 701-713
-
-
Brosh, R.1
Rotter, V.2
-
5
-
-
70349118044
-
p53: balancing tumour suppression and implications for the clinic
-
Buganim, Y. and Rotter, V. (2009). p53: balancing tumour suppression and implications for the clinic. Eur. J. Cancer 45 Suppl 1, 217-234.
-
(2009)
Eur. J. Cancer
, vol.45
, Issue.SUPPL. 1
, pp. 217-234
-
-
Buganim, Y.1
Rotter, V.2
-
6
-
-
77950239571
-
p53 regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways
-
Buganim, Y., Solomon, H., Rais, Y., Kistner, D., Nachmany, I., Brait, M., Madar, S., Goldstein, I., Kalo, E., Adam, N. et al. (2010). p53 regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. Cancer Res. 70, 2274-2284.
-
(2010)
Cancer Res
, vol.70
, pp. 2274-2284
-
-
Buganim, Y.1
Solomon, H.2
Rais, Y.3
Kistner, D.4
Nachmany, I.5
Brait, M.6
Madar, S.7
Goldstein, I.8
Kalo, E.9
Adam, N.10
-
7
-
-
0035496607
-
Rescuing the function of mutant p53
-
Bullock, A. N. and Fersht, A. R. (2001). Rescuing the function of mutant p53. Nat. Rev. Cancer 1, 68-76.
-
(2001)
Nat. Rev. Cancer
, vol.1
, pp. 68-76
-
-
Bullock, A.N.1
Fersht, A.R.2
-
8
-
-
0027983669
-
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations
-
Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
-
(1994)
Science
, vol.265
, pp. 346-355
-
-
Cho, Y.1
Gorina, S.2
Jeffrey, P.D.3
Pavletich, N.P.4
-
9
-
-
0036659130
-
Role of CXCL1 in tumorigenesis of melanoma
-
Dhawan, P. and Richmond, A. (2002). Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 72, 9-18.
-
(2002)
J. Leukoc. Biol.
, vol.72
, pp. 9-18
-
-
Dhawan, P.1
Richmond, A.2
-
10
-
-
0037264633
-
Targeting RAS signalling pathways in cancer therapy
-
Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 11-22
-
-
Downward, J.1
-
11
-
-
26444497172
-
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors
-
Dreyfus, D. H., Nagasawa, M., Gelfand, E. W. and Ghoda, L. Y. (2005). Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol. 6, 12.
-
(2005)
BMC Immunol
, vol.6
, pp. 12
-
-
Dreyfus, D.H.1
Nagasawa, M.2
Gelfand, E.W.3
Ghoda, L.Y.4
-
12
-
-
0021675797
-
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
-
Eliyahu, D., Raz, A., Gruss, P., Givol, D. and Oren, M. (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312, 646-649.
-
(1984)
Nature
, vol.312
, pp. 646-649
-
-
Eliyahu, D.1
Raz, A.2
Gruss, P.3
Givol, D.4
Oren, M.5
-
13
-
-
70349791957
-
The execution of the transcriptional axis mutant p53 E2F1 and ID4 promotes tumor neo-angiogenesis
-
Fontemaggi, G., Dell'Orso, S., Trisciuoglio, D., Shay, T., Melucci, E., Fazi, F., Terrenato, I., Mottolese, M., Muti, P., Domany, E. et al. (2009). The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat. Struct. Mol. Biol. 16, 1086-1093.
-
(2009)
Nat. Struct. Mol. Biol.
, vol.16
, pp. 1086-1093
-
-
Fontemaggi, G.1
Dell'Orso, S.2
Trisciuoglio, D.3
Shay, T.4
Melucci, E.5
Fazi, F.6
Terrenato, I.7
Mottolese, M.8
Muti, P.9
Domany, E.10
-
14
-
-
0027212498
-
Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins
-
Frangioni, J. V. and Neel, B. G. (1993). Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210, 179-187.
-
(1993)
Anal. Biochem.
, vol.210
, pp. 179-187
-
-
Frangioni, J.V.1
Neel, B.G.2
-
15
-
-
0036251645
-
TP53: a key gene in human cancer
-
Guimaraes, D. P. and Hainaut, P. (2002). TP53: a key gene in human cancer. Biochimie 84, 83-93.
-
(2002)
Biochimie
, vol.84
, pp. 83-93
-
-
Guimaraes, D.P.1
Hainaut, P.2
-
16
-
-
0025894713
-
p53 mutations in human cancers
-
Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53.
-
(1991)
Science
, vol.253
, pp. 49-53
-
-
Hollstein, M.1
Sidransky, D.2
Vogelstein, B.3
Harris, C.C.4
-
17
-
-
0030941458
-
p53, the cellular gatekeeper for growth and division
-
Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
-
(1997)
Cell
, vol.88
, pp. 323-331
-
-
Levine, A.J.1
-
18
-
-
34047223196
-
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
-
Li, Y. and Prives, C. (2007). Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene 26, 2220-2225.
-
(2007)
Oncogene
, vol.26
, pp. 2220-2225
-
-
Li, Y.1
Prives, C.2
-
19
-
-
0029062595
-
Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants
-
Lin, J., Teresky, A. K. and Levine, A. J. (1995). Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10, 2387-2390.
-
(1995)
Oncogene
, vol.10
, pp. 2387-2390
-
-
Lin, J.1
Teresky, A.K.2
Levine, A.J.3
-
20
-
-
33846243857
-
The oncogenic roles of p53 mutants in mouse models
-
Lozano, G. (2007). The oncogenic roles of p53 mutants in mouse models. Curr. Opin. Genet. Dev. 17, 66-70.
-
(2007)
Curr. Opin. Genet. Dev.
, vol.17
, pp. 66-70
-
-
Lozano, G.1
-
21
-
-
0028884084
-
Evidence for cell-specific differences in transformation by N-
-
Maher, J., Baker, D. A., Manning, M., Dibb, N. J. and Roberts, I. A. (1995). Evidence for cell-specific differences in transformation by N-, H- and K-ras. Oncogene 11, 1639-1647.
-
(1995)
H- and K-ras. Oncogene
, vol.11
, pp. 1639-1647
-
-
Maher, J.1
Baker, D.A.2
Manning, M.3
Dibb, N.J.4
Roberts, I.A.5
-
22
-
-
0025633582
-
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
-
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr, Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A. et al. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238.
-
(1990)
Science
, vol.250
, pp. 1233-1238
-
-
Malkin, D.1
Li, F.P.2
Strong, L.C.3
Fraumeni Jr, J.F.4
Nelson, C.E.5
Kim, D.H.6
Kassel, J.7
Gryka, M.A.8
Bischoff, F.Z.9
Tainsky, M.A.10
-
23
-
-
0037805547
-
RAS oncogenes: the first 30 years
-
Malumbres, M. and Barbacid, M. (2003). RAS oncogenes: the first 30 years. Nat. Rev. Cancer 3, 459-465.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 459-465
-
-
Malumbres, M.1
Barbacid, M.2
-
24
-
-
0030612937
-
Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
-
Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J. and Baldwin, A. S., Jr (1997). Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815.
-
(1997)
Science
, vol.278
, pp. 1812-1815
-
-
Mayo, M.W.1
Wang, C.Y.2
Cogswell, P.C.3
Rogers-Graham, K.S.4
Lowe, S.W.5
Der, C.J.6
Baldwin Jr, A.S.7
-
25
-
-
45749137235
-
Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
-
McMurray, H. R., Sampson, E. R., Compitello, G., Kinsey, C., Newman, L., Smith, B., Chen, S. R., Klebanov, L., Salzman, P., Yakovlev, A. et al. (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 453, 1112-1116.
-
(2008)
Nature
, vol.453
, pp. 1112-1116
-
-
McMurray, H.R.1
Sampson, E.R.2
Compitello, G.3
Kinsey, C.4
Newman, L.5
Smith, B.6
Chen, S.R.7
Klebanov, L.8
Salzman, P.9
Yakovlev, A.10
-
26
-
-
24744464071
-
Expression of MMP2 MMP9 and MMP3 in breast cancer brain metastasis in a rat model
-
Mendes, O., Kim, H. T. and Stoica, G. (2005). Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis 22, 237-246.
-
(2005)
Clin. Exp. Metastasis
, vol.22
, pp. 237-246
-
-
Mendes, O.1
Kim, H.T.2
Stoica, G.3
-
27
-
-
70449109147
-
Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma
-
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C. and Jacks, T. (2009). Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462, 104-107.
-
(2009)
Nature
, vol.462
, pp. 104-107
-
-
Meylan, E.1
Dooley, A.L.2
Feldser, D.M.3
Shen, L.4
Turk, E.5
Ouyang, C.6
Jacks, T.7
-
28
-
-
10744219897
-
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype
-
Milyavsky, M., Shats, I., Erez, N., Tang, X., Senderovich, S., Meerson, A., Tabach, Y., Goldfinger, N., Ginsberg, D., Harris, C. C. et al. (2003). Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res. 63, 7147-7157.
-
(2003)
Cancer Res
, vol.63
, pp. 7147-7157
-
-
Milyavsky, M.1
Shats, I.2
Erez, N.3
Tang, X.4
Senderovich, S.5
Meerson, A.6
Tabach, Y.7
Goldfinger, N.8
Ginsberg, D.9
Harris, C.C.10
-
29
-
-
21144456106
-
Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation
-
Milyavsky, M., Tabach, Y., Shats, I., Erez, N., Cohen, Y., Tang, X., Kalis, M., Kogan, I., Buganim, Y., Goldfinger, N. et al. (2005). Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res. 65, 4530-4543.
-
(2005)
Cancer Res
, vol.65
, pp. 4530-4543
-
-
Milyavsky, M.1
Tabach, Y.2
Shats, I.3
Erez, N.4
Cohen, Y.5
Tang, X.6
Kalis, M.7
Kogan, I.8
Buganim, Y.9
Goldfinger, N.10
-
30
-
-
23144461051
-
Genes that mediate breast cancer metastasis to lung
-
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L. and Massagué, J. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524.
-
(2005)
Nature
, vol.436
, pp. 518-524
-
-
Minn, A.J.1
Gupta, G.P.2
Siegel, P.M.3
Bos, P.D.4
Shu, W.5
Giri, D.D.6
Viale, A.7
Olshen, A.B.8
Gerald, W.L.9
Massagué, J.10
-
31
-
-
0021673319
-
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
-
Parada, L. F., Land, H., Weinberg, R. A., Wolf, D. and Rotter, V. (1984). Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312, 649-651.
-
(1984)
Nature
, vol.312
, pp. 649-651
-
-
Parada, L.F.1
Land, H.2
Weinberg, R.A.3
Wolf, D.4
Rotter, V.5
-
32
-
-
0029891536
-
p53 transactivation domain mutant Q22 S23 is impaired for repression of promoters and mediation of apoptosis
-
Roemer, K. and Mueller-Lantzsch, N. (1996). p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis. Oncogene 12, 2069-2079.
-
(1996)
Oncogene
, vol.12
, pp. 2069-2079
-
-
Roemer, K.1
Mueller-Lantzsch, N.2
-
33
-
-
27644529786
-
Tumor-derived p53 mutants induce NF- kappaB2 gene expression
-
Scian, M. J., Stagliano, K. E., Anderson, M. A., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P. and Deb, S. (2005). Tumor-derived p53 mutants induce NF- kappaB2 gene expression. Mol. Cell. Biol. 25, 10097-10110.
-
(2005)
Mol. Cell. Biol.
, vol.25
, pp. 10097-10110
-
-
Scian, M.J.1
Stagliano, K.E.2
Anderson, M.A.3
Hassan, S.4
Bowman, M.5
Miles, M.F.6
Deb, S.P.7
Deb, S.8
-
34
-
-
0026446686
-
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding
-
Shaulian, E., Zauberman, A., Ginsberg, D. and Oren, M. (1992). Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12, 5581-5592.
-
(1992)
Mol. Cell. Biol.
, vol.12
, pp. 5581-5592
-
-
Shaulian, E.1
Zauberman, A.2
Ginsberg, D.3
Oren, M.4
-
35
-
-
0034671945
-
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome
-
Sigal, A. and Rotter, V. (2000). Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788-6793.
-
(2000)
Cancer Res
, vol.60
, pp. 6788-6793
-
-
Sigal, A.1
Rotter, V.2
-
36
-
-
34247329362
-
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
-
Song, H., Hollstein, M. and Xu, Y. (2007). p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell Biol. 9, 573-580.
-
(2007)
Nat. Cell Biol.
, vol.9
, pp. 573-580
-
-
Song, H.1
Hollstein, M.2
Xu, Y.3
-
37
-
-
0033597726
-
The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis
-
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., Pinkel, D., Bissell, M. J. and Werb, Z. (1999). The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146.
-
(1999)
Cell
, vol.98
, pp. 137-146
-
-
Sternlicht, M.D.1
Lochter, A.2
Sympson, C.J.3
Huey, B.4
Rougier, J.P.5
Gray, J.W.6
Pinkel, D.7
Bissell, M.J.8
Werb, Z.9
-
38
-
-
0030957152
-
Li-Fraumeni syndrome - a molecular and clinical review
-
Varley, J. M., Evans, D. G. and Birch, J. M. (1997). Li-Fraumeni syndrome - a molecular and clinical review. Br. J. Cancer 76, 1-14.
-
(1997)
Br. J. Cancer
, vol.76
, pp. 1-14
-
-
Varley, J.M.1
Evans, D.G.2
Birch, J.M.3
-
39
-
-
0027250250
-
Mammalian Ras interacts directly with the serine/threonine kinase Raf
-
Vojtek, A. B., Hollenberg, S. M. and Cooper, J. A. (1993). Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214.
-
(1993)
Cell
, vol.74
, pp. 205-214
-
-
Vojtek, A.B.1
Hollenberg, S.M.2
Cooper, J.A.3
-
40
-
-
33645850713
-
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
-
Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S. K. and DuBois, R. N. (2006). CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203, 941-951.
-
(2006)
J. Exp. Med.
, vol.203
, pp. 941-951
-
-
Wang, D.1
Wang, H.2
Brown, J.3
Daikoku, T.4
Ning, W.5
Shi, Q.6
Richmond, A.7
Strieter, R.8
Dey, S.K.9
DuBois, R.N.10
-
41
-
-
34047198167
-
Transcription regulation by mutant p53
-
Weisz, L., Oren, M. and Rotter, V. (2007a). Transcription regulation by mutant p53. Oncogene 26, 2202-2211.
-
(2007)
Oncogene
, vol.26
, pp. 2202-2211
-
-
Weisz, L.1
Oren, M.2
Rotter, V.3
-
42
-
-
34047263449
-
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells
-
Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M., Levrero, M., Strano, S., Gorgoulis, V. G. et al. (2007b). Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res. 67, 2396-2401.
-
(2007)
Cancer Res
, vol.67
, pp. 2396-2401
-
-
Weisz, L.1
Damalas, A.2
Liontos, M.3
Karakaidos, P.4
Fontemaggi, G.5
Maor-Aloni, R.6
Kalis, M.7
Levrero, M.8
Strano, S.9
Gorgoulis, V.G.10
-
43
-
-
33847627873
-
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
-
Xia, M. and Land, H. (2007). Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat. Struct. Mol. Biol. 14, 215-223.
-
(2007)
Nat. Struct. Mol. Biol
, vol.14
, pp. 215-223
-
-
Xia, M.1
Land, H.2
|